BRCA2 and familial pancreatic carcinoma: Among unselected pancreatic cancer patient cohorts, multiple studies have shown to estimate the incidence of germline BRCA mutations ranged from 0.7–5.7% for BRCA2 and 0.3–2.3% for BRCA1 [86].